Broad Claims with narrow support – Vorrichtung zur Schwingungserzeugung from patlit.blogspot.com The decision
4 Ni 16/11 of the 4th senate of the Bundespatentgericht (BPatG) is worthwhile noting because it approaches the jurisdiction of the BPatG with a jurisdiction of the Technical Boards of Appeal of ...
Share via E–mail | Twitter | Facebook
Do people know that patents exist? A judge opines from patlit.blogspot.com OOO Abbott & Another v Design & Display Ltd & Another [2014] EWHC 2924 (IPEC) is a 4 September 2014 ruling of Judge Hacon in the Intellectual Property Enterprise Court, England and Wales, on the subject of calculation ...
Share via E–mail | Twitter | Facebook
USPTO AIA Roadshow from www.patentdocs.org The U.S. Patent and Trademark Office will be hosting seven roadshow events between September 16 and October 9 to increase understanding of the First Inventor to File (FITF) provisions of the Leahy-Smith America Invents ...
Share via E–mail | Twitter | Facebook
Conference & CLE Calendar from www.patentdocs.org September 16, 2014 - "Section 103 and Obviousness: Capitalizing on CCPA and Early Federal Circuit Precedent -- Strategies for Withstanding Obviousness Rejections and Attacks on Patent Validity and Patentability" (Strafford) - 1:00 to 2:30 pm (EDT ...
Share via E–mail | Twitter | Facebook
BCP Customer Partnership Meeting from www.patentdocs.org The U.S. Patent and Trademark Office will be holding its next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting on Wednesday, September 17, 2014. The latest BCP meeting will be the Office's first Bicoastal ...
Share via E–mail | Twitter | Facebook
Court Report from www.patentdocs.org By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Millennium Pharmaceuticals Inc. v. Glenmark Pharmaceuticals Ltd. et al. 1:14-cv-01156; filed September 10, 2014 in ...
Share via E–mail | Twitter | Facebook
WIPO Committee Advances Decisions On Programme, Budget, Oversight from www.ip-watch.org The powerful World Intellectual Property Organization Program and Budget Committee in its recent meeting worked through a tough agenda of core decisions about the UN organisation’s functioning and future. The committee reached decisions on ...
Share via E–mail | Twitter | Facebook
IPR Petitioner’s Business Model to Circumvent 35 U.S.C. § 315(b) Time Bar No Basis for Terminating Sanctions from docketreport.blogspot.com During a conference call, the Board denied the patent owner's request to file a motion for sanctions terminating the proceedings. "Patent Owner argues that [a motion for sanctions pursuant to 37 C.F.R ...
Share via E–mail | Twitter | Facebook
PTO petition republication request from allthingspros.blogspot.com C.F.R. § 1.221 allows an Applicant to correct errors in published applications by filing a petition which identifies the errors and requests republication. This week I'll review a small sample of Petition ...
Share via E–mail | Twitter | Facebook
Finding the limits of ineligibility from patentlyo.com by Dennis Crouch It is safe to say that hundreds of thousands of U.S. patents rely upon the manipulation of information or laws of nature as fundamental aspects of their respective inventions. Many of ...
Share via E–mail | Twitter | Facebook
African Declaration On Internet Rights And Freedoms from www.ip-watch.org Last week, 23 civil society groups released the African Declaration on Internet Rights and Freedoms at the Internet Governance Forum, infojustice.org reports. The declaration is organized around twelve key principles, including Freedom of Expression ...
Share via E–mail | Twitter | Facebook
Interval Licensing v. AOL: Post-Nautilus Indefiniteness from patentlyo.com By Jason Rantanen Interval Licensing LLC v. AOL, Inc. (Fed. Cir. 2014) Interval v AOL Panel: Taranto and Chen (author)* One of the most frequent criticisms of Nautilius v. Biosig is that it simply provides ...
Share via E–mail | Twitter | Facebook
Experts Look At The Meaning of Myriad, One Year Later from www.ip-watch.org IRVINE, CALIFORNIA – Experts gathered here last week addressed the question of – one year later - what does the United States Supreme Court’s decision on human gene patents mean for scientific research and patent policy?
Share via E–mail | Twitter | Facebook